Epidemiological impact of a genital herpes type 2 vaccine for young females. - Wikidata - awgldk - TriplyDB

Epidemiological impact of a genital herpes type 2 vaccine for young females.

Epidemiological impact of a genital herpes type 2 vaccine for young females.

http://www.wikidata.org/entity/Q34446935

about

Inflammasomes and Their Role in Innate Immunity of Sexually Transmitted Infections Modelling infectious diseases with relapse: a case study of HSV-2.HSV-2 and Substance Abuse amongst Adolescents: Insights through Mathematical Modelling

P2860

Q28067011-C43F7669-89A8-4F58-B114-7F22094CC84A Q33908691-766843BC-AA1B-48D6-92BA-6E334BC07707 Q59049355-BD5819E9-93E7-447E-90B1-0A5C067DE209

P2860

Epidemiological impact of a genital herpes type 2 vaccine for young females.

http://www.wikidata.org/entity/Q34446935

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Epidemiological impact of a genital herpes type 2 vaccine for young females.

@ast

Epidemiological impact of a genital herpes type 2 vaccine for young females.

@en

Epidemiological impact of a genital herpes type 2 vaccine for young females.

@nl

type

label

Epidemiological impact of a genital herpes type 2 vaccine for young females.

@ast

Epidemiological impact of a genital herpes type 2 vaccine for young females.

@en

Epidemiological impact of a genital herpes type 2 vaccine for young females.

@nl

prefLabel

Epidemiological impact of a genital herpes type 2 vaccine for young females.

@ast

Epidemiological impact of a genital herpes type 2 vaccine for young females.

@en

Epidemiological impact of a genital herpes type 2 vaccine for young females.

@nl

P1433

Q34446935-86DA1162-9936-497B-8DC9-B86679D00506

P1476

Q34446935-E200E626-1A60-48B7-8E02-3389AD978B6F

P2093

Q34446935-1963EAD1-A48E-4781-8E18-91EC38C8871E

Q34446935-5847EDFC-3B25-4563-86AB-ED03B5500082

Q34446935-74B05830-C3AC-48D2-817A-056BFC201722

Q34446935-988E5EC0-5EDC-436B-BE1F-0C1F005F9FD7

P2860

Q34446935-026546E4-CA7F-473A-B6A6-837335AD7C97

Q34446935-03B36E2A-5985-4A6A-B7A5-37688678FC1A

Q34446935-07D5D709-57C9-413F-B1B2-E7EF6421CEB2

Q34446935-14D94129-F5CB-4D02-9CEF-DB20E8EE718D

Q34446935-14FF65CE-040D-42A8-BE07-0FC56D839A97

Q34446935-1C2B1AC9-0B7C-4D2E-8161-B06345727495

Q34446935-2B3C7289-35F8-43CC-83DC-E4AE05203907

Q34446935-2EFA7DC9-B3DF-4ACC-861A-C7957B444B66

Q34446935-4328A9AA-F922-4F5B-9B58-CE34E640584D

Q34446935-46E33108-6A79-452D-AF52-E81B506E9A25

P304

Q34446935-98BB7696-E47B-4F10-BB8E-4DA169CF00AA

P31

Q34446935-FC251128-5E94-4EED-8FDD-B5527E24796D

P356

Q34446935-B76DD1BD-0C9C-4102-844F-E090ED52E0D6

P407

Q34446935-812742E2-4FD6-409A-9A1E-14F111EECC43

P433

Q34446935-11F1501B-00D3-421A-9354-A9AF63BFE1D5

P478

Q34446935-FF2170C9-3004-4A46-9D61-01BA28E440DD

P50

Q34446935-4F521A63-838E-436B-8FD0-ADCBCB11ADE1

Q34446935-C4132BDD-F414-4290-96FE-8EBDA9CFCA08

P577

Q34446935-5FFAD284-9AFC-40C5-99F1-DD13750E8931

P5875

Q34446935-DF96A6E1-471F-4A80-B3FD-42937E668074

P698

Q34446935-E40313C4-957A-4662-BFF4-9517E31CD7E4

P921

Q34446935-0B0DF291-A72E-4FC4-8F3A-3086BE3840EF

P932

Q34446935-49DE53DE-4611-47D2-9DCE-FAC2D1E582D9

P356

JOURNAL.PONE.0046027

P1433

P1476

Epidemiological impact of a genital herpes type 2 vaccine for young females.

@en

P2093

Jane M Heffernan

http://www.w3.org/2001/XMLSchema#string

Jianhong Wu

http://www.w3.org/2001/XMLSchema#string

Qian Wang

http://www.w3.org/2001/XMLSchema#string

Redouane Qesmi

http://www.w3.org/2001/XMLSchema#string

P2860

The Relationship between Condom Use and Herpes Simplex Virus Acquisition

Risk Factors for the Sexual Transmission of Genital Herpes

Perspectives on the basic reproductive ratio

Evaluating human papillomavirus vaccination programs in Canada: should provincial healthcare pay for voluntary adult vaccination?

Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.

Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2

Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years.

Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.

Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

P304

e46027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0046027

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232257167

http://www.w3.org/2001/XMLSchema#string

P698

23071536

http://www.w3.org/2001/XMLSchema#string

P921

P932

3469571

http://www.w3.org/2001/XMLSchema#string